Two faces of oesophageal cancer - epidemiology and etiology
Review articleGastroent Hepatol 2011; 65(5): 255-263.
Summarypdf Silvie Magnusková, Helena Kollárová, Vojtěch Kamarád, Katerina AzeemWhich non-steroidal anti-inflammatory drug should be used in patients with increased risk of gastrointestinal toxicity?
CommentGastroent Hepatol 2011; 65(3): 159-160.
pdf Martin Bortlík, Milan LukášXL. májové hepatologické dny, Karlovy Vary, 16. - 18. 5. 2012
SupplementumGastroent Hepatol 2012; 66(Supplementum 1): .
pdfXXXIX. májové hepatologické dny, Karlovy Vary, 10. - 13. 5. 2011
SupplementumGastroent Hepatol 2011; 65(Supplementum 1): .
pdf5. ECCO kongres, Kongresové centrum v Praze, 25.-27.2.2010
IBDČes a Slov Gastroent a Hepatol 2010; 64(2): 31-36.
pdf Milan Lukáš, Martin BortlíkAnnual report 2008 of the editor-in chief of the journal Česká a Slovenská gastroenterologie a hepatologie
NewsČes a Slov Gastroent a Hepatol 2009; 63(2): 47.
Milan KmentAnnual report of the Editor-in-Chief of the journal Czech and Slovak Gastroenterology and Hepatology for the year 2009
Annual ReportČes a Slov Gastroent a Hepatol 2010; 64(1): 4-5.
pdf Milan KmentCancer preventive vaccination against hereditary non-polyposis colorectal cancer
Letters to editorČes a Slov Gastroent a Hepatol 2010; 64(3): 39-40.
pdf Marián BátovskýCase report day of Czech Gastroenterology Society - 26 February 2009 - The Hospital Homolka, Prague - summary
Case reportČes a Slov Gastroent a Hepatol 2009; 63(3): 113-114.
Stanislav Rejchrt, Milan Chobola, Věra Tyčová, Jan Studnička, Zdeněk Vacek, Jan Bureš, Jiří Cyrany